Rapid Growth Of HER-2 Negative Breast Cancer Treatment Options

https://www.coherentmarketinsights.com/market-insight/her-2-negative-breast-cancer-market-5622
HER-2 Negative Breast Cancer Market



HER-2 negative breast cancer is a type of breast cancer that does not have high levels of the human epidermal growth factor receptor 2 (HER2) protein. HER-2 negative breast cancer represents around 70% of all breast cancer cases. Effective treatment options such as chemotherapy, surgery, radiation therapy and hormonal therapy are being increasingly used to inhibit the growth and recurrence of HER-2-negative breast cancer.


HER-2 negative breast cancer negatively impacts women's health and significantly reduces life expectancy if not treated on time. Treatment options involving chemotherapy, hormonal therapy and targeted therapy are being effectively utilized to inhibit tumor growth, reduce recurrence and improve survival rates.

The global HER-2 Negative Breast Cancer Market is estimated to be valued at US$ 13,873.7 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rapid growth is being driven by rising healthcare awareness and increasing use of targeted therapy drugs in combination with other treatment options. New drug approvals by regulatory authorities are further fueling the market growth. For instance, Pfizer's Ibrance was approved by FDA in 2015 for combination use with hormonal therapy in HER-2 negative breast cancer treatment. Eli Lilly and Company's Verzenio was also approved in 2017, creating new opportunities that are benefiting patients. Furthermore, ongoing research for developing novel therapies will continue boosting market revenues over the forecast period.
Segment Analysis

The global HER-2 negative breast cancer market is segmented on the basis of drug class, end-user and distribution channel. Based on drug class, the market is segmented into chemotherapy, targeted therapy, and others. The chemotherapy drug class segment dominated the market in 2022 owing to the high adoption and availability of generic chemotherapy drugs. However, the targeted therapy segment is expected to witness highest growth over the forecast period due to rising approval and uptake of novel targeted therapies for HER-2 negative breast cancer treatment.

Key Takeaways

The global HER-2 Negative Breast Cancer Market Growth is expected to witness high growth over the forecast period. The North America region currently dominates the market due to factors such as high cancer incidence rates, rising healthcare expenditure and presence of key market players in the region. However, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. This is attributed to growing awareness, improving healthcare infrastructure and increasing healthcare spending in emerging economies such as India and China.

Regional analysis
Asia Pacific region is projected to grow at the highest CAGR during the forecast period. Growing awareness regarding early diagnosis and treatment availability, increasing government funding for cancer research and rising healthcare expenditure are some of the factors fueling market growth in the region. Improvement in healthcare infrastructure along with increasing accessibility of medical facilities in emerging countries is also expected to boost market growth in Asia Pacific during the forecast period.

Key players
Key players operating in the HER-2 negative breast cancer market are Pfizer Inc., Novartis AG, Merck & Co. Inc., GSK PLC, AstraZeneca, Eli Lilly and Company, and Bristol-Myers Squibb Company (Celgene Corporation), among others.

Comments

Post a Comment

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Image
Agricultural Micronutrients Market Agricultural micronutrients are essential plant nutrients required in small quantities for healthy plant growth and development. Micronutrients such as iron, zinc, manganese, molybdenum, and boron play vital roles in various metabolic functions of crops such as photosynthesis, nitrogen fixation, and enzyme activity. The increasing need to boost crop yields and improve soil fertility has raised the demand for micronutrient fertilizers globally. The growing population and reducing arable land have fueled the need for sustainable agricultural practices, propelling the micronutrients market. The global Agricultural Micronutrients Market is estimated to be valued at US$ 5.19 Bn in 2024 and is expected to exhibit a CAGR of 27.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing adoption of precision farming and digital technologies in the agriculture sector is
Read more

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Image
Dairy Alternative Market Market Overview: Dairy alternative products are gaining significant popularity due to their numerous advantages. These products are plant-based, making them suitable for individuals with lactose intolerance or those following a vegan diet. They offer similar nutritional benefits as traditional dairy products such as milk, cheese, and yogurt, while also addressing concerns related to animal welfare and environmental sustainability. The growing demand for dairy alternative products among health-conscious consumers is driving market growth. Market Key Trends: One key trend observed in the dairy alternative market is the increasing preference for plant-based milk substitutes. Plant-based milk alternatives such as almond milk, soy milk, and oat milk, among others, are gaining traction among consumers as a healthier and more sustainable option compared to traditional dairy milk. These plant-based milk alternatives offer various benefits such as being lactose-free, c
Read more

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries

Image
Antimicrobial Additives Market Antimicrobial additives are extensively used in a wide range of end-use industries such as healthcare, packaging, food and beverage, construction, and automotive. These additives help protect various materials from microorganisms such as bacteria, viruses, etc. Some key applications of antimicrobial additives include packaging of food, medical devices, fabrics, flooring, coatings, etc. The ongoing COVID-19 pandemic has further increased the importance of hygiene and sanitation, driving demand for antimicrobial materials from various sectors. The global Antimicrobial Additives Market is estimated to be valued at US$ 3.47 Bn in 2024 and is expected to exhibit a CAGR of 25.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key drivers of the market's growth is the rising demand for antimicrobial additives from the packaging industry. Packaging manufacturers
Read more